Filing Flows › CTS (CTS) › Q2 2026 › vs Q2 2025
CTS (CTS) Q2 2026 vs Q2 2025 (year over year)
CTS's revenue rose $9.5M (+7%) from $135M in Q2 2025 to $145M in Q2 2026. Gross margin 41.5% against 38.7% (+2.7 pts).
CTS, Q2 2026: revenue $145M (+7% year over year), operating margin 18.5%, net earnings $19.2M, operating cash flow $33.4M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 41.5% | 38.7% | +2.7 pts |
| Operating margin | 18.5% | 16.8% | +1.7 pts |
| Net margin | 13.2% | 13.7% | -0.5 pts |
| Free cash flow margin | 19.9% | 18.5% | +1.4 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $145M | $135M | $9.5M | +7% |
| Gross profit | $60.0M | $52.4M | $7.6M | +15% |
| Cost of revenue | $84.7M | $82.9M | $1.9M | +2% |
| Operating profit | $26.8M | $22.7M | $4.1M | +18% |
| Operating expenses | $33.2M | $29.7M | $3.5M | +12% |
| Pre-tax earnings | $26.2M | $23.0M | $3.3M | +14% |
| Other expense, net | $563K | −$251K | $814K | — |
| Research & development | $4.8M | $6.3M | −$1.6M | -25% |
| SG&A | $28.4M | $23.1M | $5.3M | +23% |
| Net earnings | $19.2M | $18.5M | $640K | +3% |
| Income tax | $7.1M | $4.5M | $2.6M | +59% |
| Depreciation & amortization | $8.8M | $8.6M | $228K | +3% |
| Working capital & other | $5.5M | $1.3M | $4.2M | +330% |
| Operating cash flow | $33.4M | $28.4M | $5.1M | +18% |
| Free cash flow (OCF − capex) | $28.9M | $25.1M | $3.8M | +15% |
| Capital expenditures | $4.6M | $3.3M | $1.3M | +40% |
Questions
How much did CTS's revenue grow year over year in Q2 2026?
CTS's revenue rose $9.5M (+7%) from $135M in Q2 2025 to $145M in Q2 2026. Gross margin 41.5% against 38.7% (+2.7 pts).